Healthpeak Properties Inc. (NYSE: PEAK) stock jumped 0.45% on Friday to $24.55 against a previous-day closing price of $24.44. With 3.65 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.73 million shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $24.71 whereas the lowest price it dropped to was $24.04. The 52-week range on PEAK shows that it touched its highest point at $36.85 and its lowest point at $23.23 during that stretch. It currently has a 1-year price target of $31.62. With its current market cap of 13.24 billion, PEAK has annualized dividend of $1.20 while the current yield stands at 4.89%. Beta for the stock currently stands at 0.79.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PEAK was down-trending over the past week, with a drop of -4.47%, but this was down by -8.84% over a month. Three-month performance dropped to -3.00% while six-month performance fell -26.34%. The stock lost -29.09% in the past year, while it has lost -31.98% so far this year. A look at the trailing 12-month EPS for PEAK yields 0.40 with Next year EPS estimates of 0.45. For the next quarter, that number is 0.09. This implies an EPS growth rate of -20.10% for this year and 2.48% for next year.
Float and Shares Shorts:
At present, 539.56 million PEAK shares are outstanding with a float of 538.00 million shares on hand for trading. On Aug 30, 2022, short shares totaled 9.43 million, which was 1.75% higher than short shares on Jul 28, 2022. In addition to Mr. Thomas M. Herzog as the firm’s CEO & Non-Independent Director, Mr. Scott M. Brinker serves as its Pres & Chief Investment Officer.
Through their ownership of 96.27% of PEAK’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 59.66% of PEAK, in contrast to 40.34% held by mutual funds. Shares owned by individuals account for 0.34%. As the largest shareholder in PEAK with 15.75% of the stake, The Vanguard Group, Inc. holds 84,974,887 shares worth 84,974,887. A second-largest stockholder of PEAK, Cohen & Steers Capital Management, holds 57,428,201 shares, controlling over 10.64% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in PEAK, holding 38,816,435 shares or 7.19% stake. With a 4.59% stake in PEAK, the Vanguard Real Estate Index Fund is the largest stakeholder. A total of 24,737,357 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 2.96% of PEAK stock, is the second-largest Mutual Fund holder. It holds 15,969,071 shares valued at 419.19 million. Government Pension Fund – Global holds 2.37% of the stake in PEAK, owning 12,759,730 shares worth 334.94 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2022, PEAK reported revenue of $517.93M and operating income of $97.62M. It generated $68.34M net income for the quarter, which came to $223.42M over the last twelve months. The EBITDA in the recently reported quarter was $280.97M and diluted EPS was $0.13. EBITDA for the full year was $1.08B.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PEAK since 21 analysts follow the stock currently. There are 8 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 9 believe that the stock is worth HOLDING, 4 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With PEAK analysts setting a high price target of $36.00 and a low target of $26.00, the average target price over the next 12 months is $31.53. Based on these targets, PEAK could surge 46.64% to reach the target high and rise by 5.91% to reach the target low. Reaching the average price target will result in a growth of 28.43% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. PEAK will report FY 2022 earnings on 02/14/2023. Analysts have provided yearly estimates in a range of $0.46 being high and $0.42 being low. For PEAK, this leads to a yearly average estimate of $0.44. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Healthpeak Properties Inc. surprised analysts by $0.03 when it reported $0.13 EPS against a consensus estimate of $0.10. The surprise factor in the prior quarter was $0.04. Based on analyst estimates, the high estimate for the next quarter is $0.10 and the low estimate is $0.09. The average estimate for the next quarter is thus $0.09.
Summary of Insider Activity:
Insiders traded PEAK stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 27 while that of sell transactions has risen to 42 over the past year. The total number of shares bought during that period was 593,911 while 274,312 shares were sold.